Durham · Biotech · North Carolina

35 Durham biotech startups

As of November 2026, Triangle Startups tracks 35 biotech startups headquartered in Durham, home to Duke University and the American Underground startup hub. In the twelve months to November 2026, Durham biotech startups disclosed $72.5 million across 9 funding rounds. The last 30 days added 1 new signal on Durham biotech startups.

Latest recorded activity

Directory snapshot

Durham biotech startups by stage

Of 17 startups with a recorded funding stage, 4 are at grant, pre-seed, or seed. Reviewed jobs records currently show 11 open roles across 6 companies.

tracked startups
35
hiring now
6
grant through seed
4
By stageGrowth6Grant3Series A3Series B2Series C2

11 reviewed open roles

Which Durham biotech startups are hiring

See the jobs board

All 35 biotech startups headquartered in Durham

A

AimMax Therapeutics

Biotech

Develops drugs for infection and inflammation, including antibiotics for drug-resistant gonorrhea.

Altis Biosystems

Altis Biosystems

Biotech · Seed

Intestinal tissue models for drug development

Arbiom

Arbiom

Biotech · Growth

Fermentation company developing Torula yeast strains that transform agricultural and forestry by-products into protein and functional ingredients for food and pet-food applications.

Atsena Therapeutics

Atsena Therapeutics

Biotech · Series C

Gene therapy for inherited retinal diseases

Cell Microsystems

Cell Microsystems

Biotech · Grant

Develops proprietary tools for basic biology research

E

EpiCypher

Biotech

Sells chromatin-mapping assay kits, designer nucleosomes and genomic services for epigenetics research and drug discovery.

EydisBio Inc.

EydisBio Inc.

Biotech · Grant

Durham biotechnology company developing selective small-molecule TAK1 inhibitors for autoimmune, inflammatory, fibrotic, neurodegenerative, and infectious diseases.

ForagR Medicines

ForagR Medicines

Biotech

Drug discovery company that screens small molecules in living cells to target disease proteins through their messenger RNAs.

Gateway Bio

Gateway Bio

Biotech

Therapeutic biologics

GeneCentric

GeneCentric

Biotech · Series C

Precision-oncology diagnostics company applying gene-expression biology to liquid-biopsy sequencing through its ExpressCT fragmentomics platform and biomarker services.

Grid Therapeutics

Grid Therapeutics

Biotech

Durham clinical-stage biotech developing tumor-specific therapeutic antibodies isolated from single human B cells.

IMMvention Therapeutix

IMMvention Therapeutix

Biotech

Preclinical biotech developing oral small-molecule BACH1 inhibitors for sickle cell disease and other chronic conditions, with its systemic program licensed to Novo Nordisk.

J

Junipero Therapeutics

Biotech

Develops antisense oligonucleotides that steer a cell's own gene regulators to raise or lower expression of disease-causing genes.

Kriya Therapeutics

Kriya Therapeutics

Biotech · Growth

Gene therapy company developing AAV-based therapies for highly prevalent chronic diseases, including geographic atrophy, thyroid eye disease, and type 1 diabetes. Bicoastal since founding, with gene-therapy manufacturing and process development anchored in RTP and a Palo Alto office. Raised $320M Series D in September 2025, one of the largest NC life-sciences rounds of the year.

L

LadeRx

Biotech

Develops a manganese-based MRI contrast agent for quantitative myocardial perfusion imaging.

MAA Laboratories

MAA Laboratories

Biotech

Triangle specialty pharmaceutical company developing nanoparticle drug products through the NanoCont continuous-manufacturing platform; pipeline reformulates approved small molecules via the 505(b)(2) pathway.

Metabolon

Metabolon

Biotech · Growth

Metabolomics platform and services company providing biochemical profiling for pharmaceutical, biotech, agriculture, and consumer research.

N

NabGen, Inc.

Biotech

Develops an antibody suppressant technology that inhibits anti-drug and autoimmune antibodies, including pre-existing immunity that blocks AAV gene therapy.

N

Novo Heal, Inc.

Biotech

Develops anti-scarring regenerative therapies for vocal fold injury.

P

Parion Sciences

Biotech

Develops therapies for defects of the innate mucosal defense system in respiratory disease.

Pelthos Therapeutics

Pelthos Therapeutics

Biotech · Growth

NYSE American-listed commercial-stage pharmaceutical company marketing ZELSUVMI for molluscum contagiosum.

P

Piximune, Inc.

Biotech

Develops antibody-based treatments for inherited retinal diseases and late-stage age-related macular degeneration.

Precision BioSciences

Precision BioSciences

Biotech · Growth

Genome editing with ARCUS nuclease technology

P

Priovant Therapeutics

Biotech

Develops therapies for autoimmune diseases, including brepocitinib. NCBiotech reported its Durham operating base and the earlier FDA approval of Lisraya for adult dermatomyositis.

Ramona Optics

Ramona Optics

Biotech · Series A

Builds the Multi-Camera Array Microscope, a parallel imaging platform using micro-camera arrays, structured lighting and machine learning to capture cellular-level detail across hundreds of square centimeters at once.

Ribometrix

Ribometrix

Biotech · Series A

Small molecule drug discovery platform targeting RNA structures

Roke Biotechnologies

Roke Biotechnologies

Biotech

Develops engineered E. coli strains and two-stage processes that lower the cost of making proteins such as enzymes, therapeutic proteins, and agricultural peptides.

S

SelSym Biotech

Biotech

Develops SymClot, a synthetic platelet-mimetic hydrogel for controlling hemorrhage after trauma and surgery.

S

Sennos

Biotech · Growth

Durham-based industrial AI company building sensing, analytics, and automation for the fermentation and fluidics industries.

S

SiNON Nano Sciences

Biotech · Grant

Increases the ability of drugs to cross the Blood Brain Barrier

Tellus Therapeutics

Tellus Therapeutics

Biotech · Series A

Develops treatments for newborns in the neonatal intensive care unit. Its lead candidate, TT-20, targets white matter brain injury in preterm infants and grew out of Duke research on compounds in breast milk that restore myelination.

Ten63 Therapeutics

Ten63 Therapeutics

Biotech · Series B

AI platform for cancer drug discovery

Tune Therapeutics

Tune Therapeutics

Biotech · Series B

Epigenome editing therapeutics for chronic diseases

U

Ummino

Biotech

Produces Hummino, a precision-fermented prebiotic modeled on human milk oligosaccharides, for adult gut health.

V

Veil Therapeutics

Biotech

Develops polymer-conjugated biologics built to avoid immune detection, led by a uricase candidate for chronic gout.

Exited biotech companies headquartered in Durham

These companies have been acquired, taken private, or taken public, so each is listed with its exit and left out of the startup count above.

Browsing is free. Opening a company shows the basics; founders, funding, and signals are in the full profile behind a free account. Open roles across Triangle companies are tracked on the jobs page. Numbers refresh from the database.